The english version of the website of the School of Medicine is under development


Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease.

TitleSelenoprotein P in Patients with Nonalcoholic Fatty Liver Disease.
Publication TypeJournal Article
Year of Publication2019
AuthorsPolyzos, S. A., Kountouras J., Mavrouli M., Katsinelos P., Doulberis M., Gavana E., & Duntas L.
JournalExp Clin Endocrinol Diabetes
Date Published2019 Jan 09

OBJECTIVE: Main aim of this study was to evaluate circulating selenoprotein P (SEPP) levels in patients with simple steatosis (SS) and nonalcoholic steatohepatitis (NASH) compared with healthy controls.
METHODS: Thirty-one patients with biopsy-proven NAFLD (15 with SS, 10 with borderline NASH, 6 with definite NASH) and 27 matched controls without NAFLD were enrolled. Serum SEPP levels and liver function tests plus biochemical parameters were measured with ELISA and standard methods, respectively. Homeostatic model of assessment - insulin resistance (HOMA-IR) was calculated.
RESULTS: SEPP levels were statistically different between groups (p-value for trend=0.043). In pairwise comparisons, SEPP was lower in definite NASH compared with controls (p=0.029), but not SS (p=0.18) or borderline NASH (p=0.35). SEPP was not different between controls, SS and borderline NASH. The unadjusted trend between the controls, SS and NASH patients remained essentially unchanged after adjustment for age, sex, log(ALT) and waist circumference, but it marginally lost significance when log(HOMA-IR) entered into the model. SEPP levels were not different between groups of different severity of steatosis, fibrosis, hepatocellular ballooning, lobular and portal inflammation.
CONCLUSIONS: Lower SEPP levels were observed in patients with definite NASH compared with controls, a finding warranting larger studies.

Alternate JournalExp. Clin. Endocrinol. Diabetes
PubMed ID30625508


Secretariat of the School of Medicine


Schoole of Medicince presence in social networks
Follow Us or Connect with us.